<DOC>
	<DOCNO>NCT00667043</DOCNO>
	<brief_summary>The aim study increase knowledge drug property effect therapeutic hypothermia . The primary end point study time termination sedation extubation patient treat therapeutic hypothermia , treatment combination remifentanil propofol versus fentanyl midazolam .</brief_summary>
	<brief_title>Remifentanil Propofol Versus Fentanyl Midazolam Sedation During Therapeutic Hypothermia . A Randomised , Controlled Trial</brief_title>
	<detailed_description />
	<mesh_term>Hypothermia</mesh_term>
	<mesh_term>Propofol</mesh_term>
	<mesh_term>Remifentanil</mesh_term>
	<mesh_term>Midazolam</mesh_term>
	<mesh_term>Fentanyl</mesh_term>
	<criteria>Treatment therapeutic hypothermia follow cardiac arrest ( 3334Â°C ) analgesia/sedation require Patients must 18 year old Inclusion must approve attend physician Pregnant woman Cardiovascular unstable patient deteriorate circulatory status require multiple therapeutic measure make participation practically impossible Liver renal failure define sequential organ failure assessment ( SOFA ) score 3 4 History drug allergy , contraindication study drug Patients use schedule dose study drug . Patients know substance abuse opioids benzodiazepine</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>therapeutic hypothermia</keyword>
	<keyword>cardiac arrest</keyword>
	<keyword>sedation</keyword>
	<keyword>remifentanil</keyword>
	<keyword>propofol</keyword>
	<keyword>fentanyl</keyword>
	<keyword>midazolam</keyword>
</DOC>